• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨病毒感染在川崎病发病中的作用:COVID-19 大流行期间的一项研究。

Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic.

机构信息

Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan.

Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

J Med Virol. 2024 May;96(5):e29660. doi: 10.1002/jmv.29660.

DOI:10.1002/jmv.29660
PMID:38727136
Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, known viral diseases declined in all ages. By using the current situation as a natural experiment, this study aimed to evaluate whether the change in the incidence of Kawasaki disease (KD) during the COVID-19 pandemic varies with age and whether a specific infectious disease mediates the occurrence of KD. Monthly number of KD patients were extracted from the nationwide inpatient database. Segmented regression analysis was conducted on the interrupted time series data. Additionally, causal mediation analysis was performed to examine the role of viral infections in the changes in the number of KD patients. After the first emergency declaration for COVID-19 in Japan, there was an immediate decrease in the number of KD patients per 100 000 population aged between 6 months and 4 years (immediate change = -2.66; 95% confidence interval [CI]: -5.16 to -0.16) and aged 5-15 years (immediate change = -0.26; 95% CI: -0.49 to -0.04). However, no immediate change was observed in patients under 6 months of age. In the causal mediation analysis for each viral infection, it was found that the decrease in the number of patients with KD was mediated by changes in the number of patients with pharyngoconjunctival fever and infectious gastroenteritis. The current results suggest that viral infections may be one of the etiological agents for KD, while they may not be the main cause in early infancy. Specifically, we found that adenovirus infection and gastroenteritis was closely related to the onset of KD in some areas of Japan.

摘要

在 2019 年冠状病毒病(COVID-19)大流行期间,已知的病毒性疾病在所有年龄段的发病率均有所下降。本研究旨在利用当前形势作为自然实验,评估川崎病(KD)的发病率在 COVID-19 大流行期间的变化是否因年龄而异,以及特定的传染病是否介导 KD 的发生。从全国住院患者数据库中提取 KD 患者的每月数量。对中断时间序列数据进行分段回归分析。此外,进行因果中介分析以检查病毒感染在 KD 患者数量变化中的作用。在日本首次宣布 COVID-19 紧急状态后,6 个月至 4 岁(即时变化=-2.66;95%置信区间[CI]:-5.16 至-0.16)和 5-15 岁(即时变化=-0.26;95%CI:-0.49 至-0.04)的每 100000 人口 KD 患者数量立即减少。然而,6 个月以下的患者没有立即发生变化。在每种病毒感染的因果中介分析中,发现 KD 患者数量的减少是由咽结膜炎和传染性肠胃炎患者数量的变化介导的。目前的结果表明,病毒感染可能是 KD 的病因之一,而在婴儿早期,它们可能不是主要原因。具体来说,我们发现日本某些地区腺病毒感染和肠胃炎与 KD 的发病密切相关。

相似文献

1
Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic.探讨病毒感染在川崎病发病中的作用:COVID-19 大流行期间的一项研究。
J Med Virol. 2024 May;96(5):e29660. doi: 10.1002/jmv.29660.
2
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
8
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
9
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
10
Corticosteroids for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的皮质类固醇。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011188. doi: 10.1002/14651858.CD011188.pub2.

引用本文的文献

1
Kawasaki disease in the pre- and post-COVID-19 era: shifts in patterns and outcomes from a multi-center study.新冠疫情前后的川崎病:一项多中心研究中的模式与结局变化
Eur J Pediatr. 2025 May 29;184(6):367. doi: 10.1007/s00431-025-06211-8.